{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:24:46Z","timestamp":1761499486694,"version":"build-2065373602"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Dutch Arthritis Foundation","award":["LLP10 and UCAN-U"],"award-info":[{"award-number":["LLP10 and UCAN-U"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.berh.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:13:29Z","timestamp":1522541609000},"page":"460-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis"],"prefix":"10.1016","volume":"31","author":[{"given":"Jorg","family":"van Loosdregt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berent","family":"Prakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"Vastert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2018.02.003_bib1","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second Revision, Edmonton, 2001","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"9783","key":"10.1016\/j.berh.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: hitting the target","author":"Hinze","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2018.02.003_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.berh.2009.08.003","article-title":"New developments in the understanding of the pathophysiology and therapy","volume":"23","author":"Vastert","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2016.07.004","article-title":"Systemic-onset juvenile idiopathic arthritis","author":"Cimaz","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/eji.201546092","article-title":"Understanding inflammation in juvenile idiopathic arthritis: how immune biomarkers guide clinical strategies in the systemic onset subtype","author":"Swart","year":"2016","journal-title":"Eur J Immunol"},{"issue":"25","key":"10.1016\/j.berh.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.berh.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. the pediatric rheumatology collaborative study group and the cooperative children's study group","volume":"326","author":"Giannini","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2018.02.003_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexatehow does it really work?","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"10.1016\/j.berh.2018.02.003_bib12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.1993.03500140081040","article-title":"Anticytokine strategies in the treatment of the systemic inflammatory response syndrome","volume":"269","author":"Dinarello","year":"1993","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14712598.2013.735657","article-title":"Update on biologicals for treatment of juvenile idiopathic arthritis","volume":"13","author":"Horneff","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12969-016-0125-1","article-title":"Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation","volume":"14","author":"Armbrust","year":"2016","journal-title":"Pediatr Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib16","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/1529-0131(200011)43:11<2611::AID-ANR33>3.0.CO;2-T","article-title":"Twins concordant for juvenile rheumatoid arthritis","volume":"43","author":"Prahalad","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/art.20677","article-title":"Familial aggregation of juvenile idiopathic arthritis","volume":"50","author":"Prahalad","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2018.02.003_bib18","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/art.27516","article-title":"Quantification of the familial contribution to juvenile idiopathic arthritis","volume":"62","author":"Prahalad","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ng.2614","article-title":"Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis","volume":"45","author":"Hinks","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.24179","article-title":"Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis","volume":"60","author":"Hinks","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2018.02.003_bib21","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/art.34429","article-title":"Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13","volume":"64","author":"Thompson","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-016-0285-3","article-title":"Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility","volume":"17","author":"Finkel","year":"2016","journal-title":"BMC Med Genet"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.27688","article-title":"The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1","volume":"62","author":"Thompson","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","article-title":"Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications","volume":"76","author":"Ombrello","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"52","key":"10.1016\/j.berh.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib26","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar2041","article-title":"Novel IL10 gene family associations with systemic juvenile idiopathic arthritis","volume":"8","author":"Fife","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gene.2008.24","article-title":"Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis","volume":"9","author":"Stock","year":"2008","journal-title":"Gene Immun"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-11-14","article-title":"Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis","volume":"11","author":"Hinks","year":"2013","journal-title":"Pediatr Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2018.02.003_bib29","doi-asserted-by":"crossref","first-page":"e47673","DOI":"10.1371\/journal.pone.0047673","article-title":"Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA)","volume":"7","author":"Omoyinmi","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2017.09.010","article-title":"The DNA methylation landscape of CD4(+) T cells in oligoarticular juvenile idiopathic arthritis","volume":"86","author":"Chavez-Valencia","year":"2018","journal-title":"J\u00a0Autoimmun"},{"issue":"50","key":"10.1016\/j.berh.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6099","key":"10.1016\/j.berh.2018.02.003_bib33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"issue":"7539","key":"10.1016\/j.berh.2018.02.003_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.berh.2018.02.003_bib35","first-page":"7","article-title":"Autoimmune disease-associated gene expression is reduced by BET-inhibition","author":"Peeters","year":"2016","journal-title":"Genomics Data"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1189\/jlb.1112588","article-title":"The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis","volume":"95","author":"Belkina","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib37","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.4049\/jimmunol.1202838","article-title":"BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses","volume":"190","author":"Belkina","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib38","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1084\/jem.20130376","article-title":"BET bromodomain inhibition suppresses TH17-mediated pathology","volume":"210","author":"Mele","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"36","key":"10.1016\/j.berh.2018.02.003_bib39","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1073\/pnas.1212264109","article-title":"Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors","volume":"109","author":"Bandukwala","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molcel.2014.05.018","article-title":"Chromatin reader Brd4 functions in Ig class switching as a repair complex adaptor of nonhomologous end-joining","volume":"55","author":"Stanlie","year":"2014","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/j.berh.2018.02.003_bib41","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bbadis.2014.05.013","article-title":"I-BET151 selectively regulates IL-6 production","volume":"1842","author":"Barrett","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","article-title":"Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling","volume":"39","author":"Qiao","year":"2013","journal-title":"Immunity"},{"issue":"7327","key":"10.1016\/j.berh.2018.02.003_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/eji.201444862","article-title":"BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak-STAT signaling in a gene-specific manner in human monocytes","volume":"45","author":"Chan","year":"2015","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nsmb.2399","article-title":"Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II","volume":"19","author":"Larochelle","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.berh.2018.02.003_bib47","doi-asserted-by":"crossref","first-page":"31441","DOI":"10.1038\/srep31441","article-title":"Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis","volume":"6","author":"Hellvard","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.berh.2018.02.003_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2015.08.046","article-title":"Inhibition of super-enhancer activity in autoinflammatory site-derived T Cells reduces disease-associated gene expression","volume":"12","author":"Peeters","year":"2015","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib49","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2352-3026(15)00247-1","article-title":"Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study","volume":"3","author":"Berthon","year":"2016","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib50","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2352-3026(16)00021-1","article-title":"Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study","volume":"3","author":"Amorim","year":"2016","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/35.7.689","article-title":"Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?","volume":"35","author":"Malin","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10787-997-0001-1","article-title":"Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms","volume":"5","author":"Malin","year":"1997","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.berh.2018.02.003_bib54","first-page":"773","article-title":"Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters","volume":"18","author":"Picco","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib55","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1542\/peds.2015-0036","article-title":"Antibiotic exposure and juvenile idiopathic arthritis: A case-control study","volume":"136","author":"Horton","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2249.2012.04663.x","article-title":"Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis","volume":"170","author":"Arvonen","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"Pt 11","key":"10.1016\/j.berh.2018.02.003_bib57","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10096-015-2548-x","article-title":"Faecal microbiome in new-onset juvenile idiopathic arthritis","volume":"35","author":"Tejesvi","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib60","doi-asserted-by":"crossref","first-page":"e80201","DOI":"10.1371\/journal.pone.0080201","article-title":"Differential effects of antibiotic therapy on the structure and function of human gut microbiota","volume":"8","author":"Perez-Cobas","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib61","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/gutjnl-2012-303184","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach","volume":"62","author":"Perez-Cobas","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.berh.2018.02.003_bib62","doi-asserted-by":"crossref","first-page":"e49868","DOI":"10.1371\/journal.pone.0049868","article-title":"Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk","volume":"7","author":"IJssennagger","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/intimm\/11.4.535","article-title":"Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood","volume":"11","author":"Wedderburn","year":"1999","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.1993.tb03360.x","article-title":"Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue","volume":"91","author":"Silverman","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1345\/aph.10123","article-title":"Etanercept in juvenile rheumatoid arthritis","volume":"35","author":"Johnson","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.berh.2018.02.003_bib66","first-page":"2116","article-title":"Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis","volume":"23","author":"Murray","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"2 Suppl","key":"10.1016\/j.berh.2018.02.003_bib67","first-page":"271","article-title":"Pathologic aspects of juvenile chronic polyarthritis","volume":"20","author":"Bywaters","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","article-title":"T\u00a0cells out of control\u2013impaired immune regulation in the inflamed joint","volume":"9","author":"Wehrens","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib69","first-page":"449","article-title":"Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint","volume":"29","author":"Nistala","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib70","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2018.02.003_bib72","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3899\/jrheum.090066","article-title":"Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis","volume":"36","author":"Olivito","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.immuni.2011.12.013","article-title":"Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion","volume":"36","author":"Santarlasci","year":"2012","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.berh.2018.02.003_bib74","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2018.02.003_bib75","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.berh.2018.02.003_bib76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib77","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.berh.2018.02.003_bib78","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"De Kleer","year":"2004","journal-title":"J\u00a0Immunol (Baltimore, Md 1950)"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib79","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.11174","article-title":"The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10","volume":"48","author":"De Kleer","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib80","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.164.5.2711","article-title":"A\u00a0conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue","volume":"164","author":"Wendling","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib81","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/art.20635","article-title":"Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein","volume":"50","author":"Quintana","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib82","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.39444","article-title":"An arthritis-suppressive and treg cell-inducing CD4+ T cell epitope is functional in the context of HLA-restricted T cell responses","volume":"68","author":"De Wolf","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.berh.2018.02.003_bib83","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3389\/fimmu.2017.01690","article-title":"The Immunomodulatory Potential of tolDCs Loaded with Heat Shock Proteins","volume":"8","author":"Van Eden","year":"2017","journal-title":"Front Immunol"},{"issue":"9479","key":"10.1016\/j.berh.2018.02.003_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(05)66827-4","article-title":"Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis","volume":"366","author":"Kamphuis","year":"2005","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib85","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.22567","article-title":"Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis","volume":"56","author":"Massa","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.berh.2018.02.003_bib86","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","article-title":"Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells","volume":"118","author":"Wehrens","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib87","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"Van Loosdregt","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib88","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2013.07.019","article-title":"Canonical Wnt signaling negatively modulates regulatory T cell function","volume":"39","author":"Van Loosdregt","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.berh.2018.02.003_bib89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","article-title":"Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity","volume":"39","author":"Van Loosdregt","year":"2013","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.berh.2018.02.003_bib90","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In\u00a0vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/kel346","article-title":"Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue","volume":"46","author":"Gattorno","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"33","key":"10.1016\/j.berh.2018.02.003_bib93","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"10.1016\/j.berh.2018.02.003_bib94","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.0906988106","article-title":"IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells","volume":"106","author":"Guo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib95","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.berh.2018.02.003_bib96","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2012.11.002","article-title":"Differentiation and function of Foxp3+ effector regulatory T cells","author":"Cretney","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.berh.2018.02.003_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.pmbts.2015.08.005","article-title":"Development and Function of Effector Regulatory T Cells","author":"Teh","year":"2015","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"10","key":"10.1016\/j.berh.2018.02.003_bib98","article-title":"Utilization of biologic and non-biologic disease modifying anti-rheumatic drugs in the treatment of juvenile idiopathic arthritis: A cross-sectional analysis of the childhood arthritis and rheumatology research alliance registry","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib99","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22259","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis","volume":"66","author":"Ringold","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.berh.2018.02.003_bib101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrrheum.2014.208","article-title":"Advances in biomarkers for paediatric rheumatic diseases","volume":"11","author":"Consolaro","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2018.02.003_bib102","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in\u00a0vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib103","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.0803474","article-title":"High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population","volume":"185","author":"Moncrieffe","year":"2010","journal-title":"J\u00a0Immunol (Baltimore, Md 1950)"},{"issue":"9","key":"10.1016\/j.berh.2018.02.003_bib104","article-title":"Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis","volume":"54","author":"\u0106alasan","year":"2015","journal-title":"Rheumatol"},{"key":"10.1016\/j.berh.2018.02.003_bib105","series-title":"Novartis found symp. Kennedy institute of rheumatology division, faculty of medicine, Imperial college of science, technology and medicine, 1 Aspenlea road, London W6 8LH, UK","first-page":"53","article-title":"Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?","volume":"256","author":"Feldmann","year":"2004"},{"issue":"8657","key":"10.1016\/j.berh.2018.02.003_bib106","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib107","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1136\/annrheumdis-2012-201991","article-title":"Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons","volume":"72","author":"Otten","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2018.02.003_bib108","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.berh.2018.02.003_bib109","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis","volume":"342","author":"Lovell","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.berh.2018.02.003_bib111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib112","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.berh.2018.02.003_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/art.38132","article-title":"Brief report: Anti-tumor necrosis factor \u03b1 targets protein kinase B\/c-akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis","volume":"65","author":"Wehrens","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib114","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/14740338.2015.1042453","article-title":"Safety of biologic therapies for the treatment of juvenile idiopathic arthritis","volume":"14","author":"Horneff","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.berh.2018.02.003_bib115","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2018.02.003_bib116","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1038\/sj.bmt.1703946","article-title":"Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis","volume":"32","author":"Wulffraat","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"9152","key":"10.1016\/j.berh.2018.02.003_bib117","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)05399-9","article-title":"Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis","volume":"353","author":"Wulffraat","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.berh.2018.02.003_bib118","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.02.003_bib119","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network","volume":"107","author":"De Kleer","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"issue":"7548","key":"10.1016\/j.berh.2018.02.003_bib121","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature14154","article-title":"Super-enhancers delineate disease-associated regulatory nodes in T cells","volume":"520","author":"Vahedi","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib122","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12969-017-0212-y","article-title":"Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study","volume":"15","author":"Ruperto","year":"2017","journal-title":"Pediatr Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2018.02.003_bib123","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2015.1037282","article-title":"The therapeutic potential of regulatory T cells for the treatment of autoimmune disease","volume":"19","author":"Bluestone","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.berh.2018.02.003_bib124","first-page":"654","article-title":"Inducing and Administering Tregs to Treat Human Disease","volume":"6","author":"Perdigoto","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.berh.2018.02.003_bib125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.berh.2018.02.003_bib126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","article-title":"Update on mesenchymal stem cell-based therapy in lupus and scleroderma","volume":"17","author":"Cras","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2018.02.003_bib127","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrrheum.2013.166","article-title":"Mesenchymal stem cell treatments in rheumatology: a glass half full?","author":"Tyndall","year":"2014","journal-title":"Nat Rev Rheumatol"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:24Z","timestamp":1761499104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694218300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1521694218300056"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.02.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"type":"print","value":"1521-6942"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}